These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38493247)

  • 1. A new model using deep learning to predict recurrence after surgical resection of lung adenocarcinoma.
    Kim PJ; Hwang HS; Choi G; Sung HJ; Ahn B; Uh JS; Yoon S; Kim D; Chun SM; Jang SJ; Go H
    Sci Rep; 2024 Mar; 14(1):6366. PubMed ID: 38493247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma.
    Jones GD; Brandt WS; Shen R; Sanchez-Vega F; Tan KS; Martin A; Zhou J; Berger M; Solit DB; Schultz N; Rizvi H; Liu Y; Adamski A; Chaft JE; Riely GJ; Rocco G; Bott MJ; Molena D; Ladanyi M; Travis WD; Rekhtman N; Park BJ; Adusumilli PS; Lyden D; Imielinski M; Mayo MW; Li BT; Jones DR
    JAMA Surg; 2021 Feb; 156(2):e205601. PubMed ID: 33355651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep learning-based analysis of EGFR mutation prevalence in lung adenocarcinoma H&E whole slide images.
    Park JH; Lim JH; Kim S; Kim CH; Choi JS; Lim JH; Kim L; Chang JW; Park D; Lee MW; Kim S; Park IS; Han SH; Shin E; Roh J; Heo J
    J Pathol Clin Res; 2024 Nov; 10(6):e70004. PubMed ID: 39358807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eight-gene signature predicts recurrence in lung adenocarcinoma.
    Zhang Y; Fan Q; Guo Y; Zhu K
    Cancer Biomark; 2020; 28(4):447-457. PubMed ID: 32508318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel transcriptomic signature associated with lymphovascular invasion predicts clinical outcomes, tumor microenvironment, and therapeutic response in lung adenocarcinoma.
    Huang X; Feng Y; Li Y; Ding H; Huang X; Chen C; Yu Z; Zhang J; Xu X; Ma D; Yu S; Chen C
    Int Immunopharmacol; 2024 Jan; 127():111286. PubMed ID: 38064818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different pathologic types of early stage lung adenocarcinoma have different post-operative recurrence patterns.
    Liu X; Sun K; Yang F; Sui X; Jiang G; Wang J; Li X
    Thorac Cancer; 2021 Aug; 12(15):2205-2213. PubMed ID: 34180578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spread through air spaces is an independent predictor of recurrence in stage III (N2) lung adenocarcinoma.
    Terada Y; Takahashi T; Morita S; Kashiwabara K; Nagayama K; Nitadori JI; Anraku M; Sato M; Shinozaki-Ushiku A; Nakajima J
    Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):442-448. PubMed ID: 31106332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Recurrence-Specific Gene-Based Prognosis Prediction Model for Lung Adenocarcinoma through Machine Learning Algorithm.
    Xu S; Zhou J; Liu K; Chen Z; He Z
    Biomed Res Int; 2020; 2020():9124792. PubMed ID: 33224985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial intelligence-based recurrence prediction outperforms classical histopathological methods in pulmonary adenocarcinoma biopsies.
    Akram F; Wolf JL; Trandafir TE; Dingemans AC; Stubbs AP; von der Thüsen JH
    Lung Cancer; 2023 Dec; 186():107413. PubMed ID: 37939498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of tumor spread through air spaces in patients with stage IA part-solid lung adenocarcinoma after sublobar resection.
    Chae M; Jeon JH; Chung JH; Lee SY; Hwang WJ; Jung W; Hwang Y; Cho S; Kim K; Jheon S
    Lung Cancer; 2021 Feb; 152():21-26. PubMed ID: 33338924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images.
    Sadhwani A; Chang HW; Behrooz A; Brown T; Auvigne-Flament I; Patel H; Findlater R; Velez V; Tan F; Tekiela K; Wulczyn E; Yi ES; Mermel CH; Hanks D; Chen PC; Kulig K; Batenchuk C; Steiner DF; Cimermancic P
    Sci Rep; 2021 Aug; 11(1):16605. PubMed ID: 34400666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DeepRePath: Identifying the Prognostic Features of Early-Stage Lung Adenocarcinoma Using Multi-Scale Pathology Images and Deep Convolutional Neural Networks.
    Shim WS; Yim K; Kim TJ; Sung YE; Lee G; Hong JH; Chun SH; Kim S; An HJ; Na SJ; Kim JJ; Moon MH; Moon SW; Park S; Hong SA; Ko YH
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-Based Deep-Learning Model for Spread-Through-Air-Spaces Prediction in Ground Glass-Predominant Lung Adenocarcinoma.
    Lin MW; Chen LW; Yang SM; Hsieh MS; Ou DX; Lee YH; Chen JS; Chang YC; Chen CM
    Ann Surg Oncol; 2024 Mar; 31(3):1536-1545. PubMed ID: 37957504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK2 Loss Arising From Tumor-Spread-Through-Air-Spaces (STAS) Promotes Tumor Progression by Suppressing CD8+ T Cells in Lung Adenocarcinoma: A Machine Learning Approach.
    Choi S; Kim HS; Min KW; Noh YK; Lee JY; Moon JY; Jung US; Kwon MJ; Kim DH; Son BK; Pyo JS; Ro SK
    J Korean Med Sci; 2024 Jan; 39(2):e16. PubMed ID: 38225784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of postoperative recurrence with radiological and clinicopathological features in patients with stage IA-IIA lung adenocarcinoma.
    Zhang Y; Zhao F; Wu M; Zhao Y; Liu Y; Li Q; Zhou G; Ye Z
    Eur J Radiol; 2021 Aug; 141():109802. PubMed ID: 34090112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [To evaluate the clinicopathologic characteristics and outcome of tumor cells spreading through air spaces in patients with adenocarcinoma of lung].
    Sun PL; Liu JN; Cao LQ; Yao M; Gao HW
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):303-308. PubMed ID: 28468034
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinicopathological, gene expression and genetic features of stage I lung adenocarcinoma with necrosis.
    Oiwa H; Aokage K; Suzuki A; Sato K; Kuroe T; Mimaki S; Tane K; Miyoshi T; Samejima J; Tsuchihara K; Goto K; Funai K; Tsuboi M; Nakai T; Ishii G
    Lung Cancer; 2021 Sep; 159():74-83. PubMed ID: 34311347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in Lung Adenocarcinoma.
    Hayasaka K; Shiono S; Matsumura Y; Yanagawa N; Suzuki H; Abe J; Sagawa M; Sakurada A; Katahira M; Takahashi S; Endoh M; Okada Y
    Ann Thorac Surg; 2018 Jun; 105(6):1648-1654. PubMed ID: 29486179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited Resection Is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces.
    Kadota K; Kushida Y; Kagawa S; Ishikawa R; Ibuki E; Inoue K; Go T; Yokomise H; Ishii T; Kadowaki N; Haba R
    Am J Surg Pathol; 2019 Aug; 43(8):1033-1041. PubMed ID: 31107717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma.
    Ito M; Miyata Y; Kushitani K; Ueda D; Takeshima Y; Okada M
    BMC Cancer; 2023 Mar; 23(1):248. PubMed ID: 36918771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.